Key Points

Seoul stocks experienced a significant drop, falling over 2% due to escalating tariff concerns and reduced hopes for U.S. Federal Reserve rate cuts. The KOSPI closed below the 3,400-point mark for the first time in ten sessions, signaling market volatility. Foreign and institutional investors were major sellers, while retail investors attempted to capitalize on the dip. High-profile companies like Samsung Electronics and SK hynix saw their shares plummet amid broader market uncertainty.

Key Points: Seoul Stocks Plunge 2 Percent Amid Tariff Concerns and Fed Outlook

  • Seoul stocks drop over 2% due to tariff concerns and Fed news
  • KOSPI closes below 3,400 points for the first time in ten sessions
  • Foreign and institutional investors lead the sell-off, retail investors buy
  • Samsung Electronics and SK hynix shares see significant declines
2 min read

Seoul shares dip over 2 pc on tariff woes, reduced Fed rate cut hopes

South Korean stocks fall over 2% on tariff issues and reduced Fed rate cut hopes, with KOSPI closing below 3,400 points.

"The remark cast doubt on the initial Korea-U.S. trade agreement in August. - Lee Jae-won, Shinhan Securities Co."

Seoul, Sep 26

South Korean stocks tumbled more than 2 per cent on Friday, falling below the 3,400-point threshold for the first time in 10 sessions on escalating tariff woes and diminished hopes for U.S. rate cuts.

The local currency also nosedived, piercing the 1,410 won mark against the U.S. dollar for the first time in more than four months as investors rushed to safer assets, reports Yonhap news agency.

The benchmark Korea Composite Stock Price Index (KOSPI) lost 85.06 points, or 2.45 percent, to close at 3,386.05. It marked the first 3,300-line finish since Sept. 12, when the index closed at 3.395.54.

Trade volume was moderate at 389 million shares worth 12.2 trillion won (US$8.63 billion), with losers sharply outnumbering winners 776 to 121.

Foreign and institutional investors led the sharp decline, dumping a net 661.1 billion won and 489 billion won worth of shares, respectively. Meanwhile, retail investors purchased a net 1.1 trillion won.

Analysts pointed out that the market was weighed heavily down by U.S. President Donald Trump's overnight comments that South Korea's planned investment worth $350 billion is just "up front."

"The remark cast doubt on the initial Korea-U.S. trade agreement in August," Lee Jae-won, an analyst at Shinhan Securities Co., said. "Investors are also concerned over the trade talks, which have made no progress yet."

Also, stronger-than-earlier growth in the world's largest economy reduced hopes for the Federal Reserve's imminent rate cuts.

Most shares closed in negative territory across the board.

Market bellwether Samsung Electronics sank 3.25 percent to 83,300 won, and chipmaker SK hynix slumped 5.61 percent to 336,500 won.

Top carmaker Hyundai Motor retreated 1.15 percent to 214,500 won, and its auto parts affiliate Hyundai Mobis declined 1.99 percent to 295,000 won.

Drugmakers were mixed following a U.S. government announcement on levying 100 percent tariffs on imported branded drugs. Samsung Biologics lost 2.15 percent to 1 million, while Celltrion edged up 0.06 percent to 178,000 won.

Defence giant Hanwha Aerospace skidded 0.38 percent to 1.04 million won, and leading food company CJ Cheiljedang decreased 1.5 percent to 230,500 won.

Kakao slumped 6.17 percent to 59,300 won on growing public complaints about a recent update on its popular messenger app KakaoTalk.

The local currency was quoted at 1,412.4 won against the greenback at 3:30 p.m., down 11.8 won from the previous session. It marked the highest won-dollar rate quoted at 3:30 p.m. since May 14, when it was 1,420.2 won.

- IANS

Share this article:

Reader Comments

S
Sarah B
Interesting to see retail investors in Korea buying the dip while institutions sold. Same pattern we see in India sometimes. Retail investors often have more patience for long-term gains.
P
Priya S
The 100% tariffs on imported branded drugs could actually benefit Indian pharma companies. We export so many generic drugs to the US. Might be an opportunity for Sun Pharma and Dr Reddy's. 💊
A
Arjun K
Trump's unpredictable trade policies are creating uncertainty worldwide. This volatility affects emerging markets like India the most. RBI needs to be prepared for currency fluctuations.
M
Michael C
While the article is about Korea, it's a good reminder for Indian investors to not put all eggs in one basket. Diversification across sectors and geographies is key in today's global economy.
N
Neha E
The KakaoTalk update causing stock drop shows how sensitive tech stocks are to user experience. Indian tech companies should learn from this - customer satisfaction directly impacts valuation.
V
Vikram M
With Fed rate cuts looking less likely, foreign investors might pull out from emerging markets. This could put pressure on Indian stocks too. Time to be cautious with new investments.

We welcome thoughtful discussions from our readers. Please keep comments respectful and on-topic.

Leave a Comment

Minimum 50 characters 0/50